BioPharma Provides $500MM Term Loan for TESARO
TESARO, an oncology-focused biopharmaceutical company, entered into a definitive term loan agreement with Biopharma Credit and BioPharma Credit Investments IV, investment funds managed by Pharmakon Advisors.
November 27, 2017
Biopharma Credit | Biopharma Credit Investments IV | Gonzalez de Cosio | Pharmakon Advisors | Tesaro
ABF Journal